You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TXG Sale Disclosure
Stuelpnagel John R · SEC Form 4 · Filed Aug 13, 2026
Sale
Calculated transaction value
$978.88K
Stuelpnagel John R Director
TXG
10x Genomics
TXG
Transaction date
Aug 11, 2026
Public filing date
Aug 13, 2026
Filing lag
Filed 2 days later
TXG daily price context
Close on/before transaction
$58.48
Aug 11, 2026
First close after public filing
$56.09
Aug 14, 2026
30-day return after filing
+25.0%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 17,000 shares @ $57.58
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001610717-26-000358
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$1.16M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| 10x Genomics, Inc. TXG Current | Sale | Aug 11, 2026 | $978.88K |
| 10x Genomics, Inc. TXG | Sale | Aug 11, 2026 | $176.18K |